Browse EX-10 agreements

EXECUTION VERSION

TRANSITION AGREEMENT

This TRANSITION AGREEMENT (the “Agreement”), dated this 26th day of July, 2026 (the “Effective Date”), is by and between Cracker Barrel Old Country Store, Inc., a Tennessee corporation (the “Company”), and Julie Masino (the “Executive”).

W I T N E S S E T H:

WHEREAS, the Company and the Executive are parties to an Employment Agreement dated July 17, 2023 (the “Existing Employment Agreement”), pursuant to which the Executive currently serves as the Company’s President and Chief Executive Officer, and the Executive also serves as a director on the Company’s Board of Directors (the “Board”); and

WHEREAS, the Company and the Executive have agreed that the Executive’s employment will terminate pursuant to the Existing Employment Agreement, and to provide for the orderly and effective transition of Company leadership to a successor President and Chief Executive Officer and to secure the Executive’s services in connection with such transition on the terms and conditions specified herein; and

…

EXECUTION VERSION

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the “Agreement”), dated this 26th day of July, 2026, is by and between Cracker Barrel Old Country Store, Inc., a Tennessee corporation (the “Company”), and David Deno (“Executive”).

W I T N E S S E T H:

WHEREAS, the Board of Directors of the Company (“Board”) wishes to hire Executive to serve as the Company’s President and Chief Executive Officer; and

WHEREAS, Executive is willing to serve in such capacity on the terms and conditions specified herein; and

WHEREAS, in order to effect the foregoing purposes, the Company and Executive wish to enter into this Agreement on the terms and conditions set forth below.

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises and covenants set forth below and other good and valuable consideration, the receipt of which is hereby acknowledged, the Company and Executive do hereby agree as follows:

1.              Employment; Position; Duties; Full-Time Status.

…

***CONSULTING AND ADVISORY AGREEMENT ***

This CONSULTING AND ADVISORY AGREEMENT (this “Agreement”) is entered into as of July 26, 2026 by and between Sarepta Therapeutics, Inc. (the “Company”) and Douglas S. Ingram, an individual (“Consultant”).

WHEREAS, Consultant is retiring from his employment with the Company as its Chief Executive Officer (“Retirement”) effective as of July 28, 2026 (the “Effective Date”);

WHEREAS, Consultant has agreed to act as an advisor to the Company following his Retirement; and

WHEREAS, the Company and Consultant desire to enter into this Agreement setting forth the terms of Consultant’s consulting and advisory relationship with the Company and certain other matters relating to his transition to an advisor role.

NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements herein contained, the parties hereto agree as follows:

…

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of July 24, 2026 by and between Sarepta Therapeutics, Inc. (the “Company”) and Michael Severino, M.D. (the “Executive”), and is effective as of July 28, 2026 (the “Effective Date”).

WHEREAS, the Executive possesses certain experience and expertise that qualifies him to provide the direction and leadership required by the Company; and

WHEREAS, the Company desires to employ the Executive as Chief Executive Officer of the Company and the Executive wishes to accept such employment;

NOW, THEREFORE, in consideration of the mutual covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows:

1. **Position and Duties; Term. **

…

Execution Version

FIRST AMENDMENT TO CREDIT AGREEMENT

This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), is entered into as of July 24, 2026, among Solstice Advanced Materials Inc., a Delaware corporation (the “Borrower”), the Lenders (as defined below) party hereto (the “Consenting Lenders”), and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”).

W I T N E S S E T H:

WHEREAS the Borrower, the Administrative Agent, the several lenders and issuing banks from time to time party thereto (the “Lenders”), are party to that certain Credit Agreement, dated as of October 29, 2025 (as amended, restated, amended and restated or otherwise modified or supplemented prior to the date hereof, the “Credit Agreement” and as amended by this Amendment, the “Amended Credit Agreement”).

…

AMENDMENT NO. 1 AND FORBEARANCE / EXTENSION AGREEMENT TO ASSET PURCHASE AGREEMENT

** **

This **Amendment No. 1 and Forbearance / Extension Agreement to Asset Purchase Agreement **(this “Amendment”) is entered into and effective as of **July 23, 2026 **(the “Amendment Effective Date”), by and between Kustom Entertainment, Inc., a Nevada corporation (“Kustom”), and Cycurion, Inc., a Delaware corporation (“CYCU”). Kustom and CYCU are referred to collectively as the “Parties” and individually as a “Party.”

RECITALS

** **

WHEREAS, the Parties entered into that certain **Asset Purchase Agreement dated June 23, 2026 **(the “Original APA”), pursuant to which Kustom agreed to sell, and CYCU agreed to acquire the Video Solutions Business assets of Kustom on the terms and conditions set forth therein;

** **

WHEREAS, the transaction contemplated by the Original APA was required to close on or before the closing date specified in the Original APA of July 15, 2026;

** **

…

​

Exhibit 10.1

RETIREMENT PLAN FOR DIRECTORS EMERITUS

​

Sierra Bancorp (hereinafter, the “Company”), established the position of Director Emeritus and adopted the Retirement Plan for Directors Emeritus (the “Plan”), effective as of July 23, 2026. The Plan is designed to provide retirement benefits for qualified non-employee directors (each, an “Eligible Director”) of the Company’s Board of Directors (the “Company Board”), and members of the board (“Bank Board”) of its wholly owned subsidiary, Bank of the Sierra (the “Bank”), and to help ensure the Company’s and Bank’s continued ability to retain highly qualified directors.

…

DEBT Conversion Agreement

This Debt Conversion Agreement (this “Agreement”) is entered into effective as of July 24, 2026 (the “Effective Date”), by and among Generation Income Properties, L.P., a Delaware limited partnership (the “Company”), Generation Income Properties, Inc., a Maryland corporation (“Parent”), and the David E. Sobelman Revocable Trust, under Agreement dated September 5, 2007 (“Sobelman”).

W I T N E S S E T H

WHEREAS, the Company previously issued that certain Promissory Note, dated as of May 29, 2025, to Sobelman, in the original principal amount of Six Hundred Ten Thousand and 00/100 Dollars ($610,000.00) (as amended, restated, supplemented, or otherwise modified from time to time, the “Note”);

WHEREAS, as of the date hereof, the aggregate outstanding principal amount under the Note, together with all accrued and unpaid interest thereon, is $[____] (the “Outstanding Debt”);

…

**FORM OF SUBSCRIPTION AGREEMENT **

This **SUBSCRIPTION AGREEMENT **(this “Subscription Agreement”) is entered into on July 26, 2026 by and between RESEARCH ALLIANCE CORPORATION III, a Cayman Islands exempted company (the “Company”), and the subscriber party set forth on the signature page hereto (the “Subscriber”), acting severally and not jointly with any Other Subscriber (as defined below).

**RECITALS **

WHEREAS, substantially concurrently with the execution of this Subscription Agreement, the Company is entering into a business combination agreement (the “Business Combination Agreement”) with OHB Pediatrics Ltd., a company incorporated under the laws of England and Wales (“OHBP”), and such other holders of shares of OHBP party thereto and whose names are set out in Schedule 1a to the Business Combination Agreement (“OHBP Shareholders”), pursuant to which (and subject to the terms and conditions set forth therein), the Company will acquire OHBP and the OHBP Shareholders will sell their shares in the capital of OHBP to the Company in c

…

**SPONSOR LETTER AGREEMENT **

This Sponsor Letter Agreement (this “Agreement”), dated as of July 26, 2026, is made by and among Research Alliance Holdings III LLC, a Cayman Islands limited liability company (the “Sponsor”), Research Alliance Corporation III, a Cayman Islands exempted company (“RACC”), the other holders of RACC Class B ordinary shares, par value $0.0001 per share (the “Class********* B Shares***”) set forth on Schedule I hereto (the “Other Class********* B Holders***”, and together with the Sponsor, collectively, the “Class********* B Holders***”), and OHB Pediatrics Ltd. (company number 15958711 incorporated under the laws of England and Wales) (the “Company”). The Sponsor, the Other Class B Holders, RACC and the Company shall be referred to herein from time to time collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined below).

…

THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED IN THIS SAFE AND UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

**OHB PEDIATRICS LTD. **

**SAFE **

**(Simple Agreement for Future Equity) **

THIS CERTIFIES THAT in exchange for the payment by [Investor Name] (the “Investor”) of $[_____________] (the “Purchase Amount”) to an account provided by OHB Pediatrics Ltd., company number 15958711 incorporated under the laws of England and Wales (the “Company”) on or about [•], 2026, the Company issues to the Investor the right to certain shares of the Company’s Capital Shares, subject to the terms described below.

**1. Events **

(a) Conversion Events.

…

**FORM OF INVESTOR RIGHTS AGREEMENT **

THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is dated as of [•], 2026, and is entered into by and among Oak Hill Bio, Inc., a Delaware corporation (“OAKH”) (formerly known as Research Alliance Corporation III, a Cayman Islands exempted company, prior to its transfer by way of continuation and domestication as a Delaware corporation), Research Alliance Holdings III LLC, a Cayman Islands exempted company (the “Sponsor”), certain investment vehicles affiliated with the Sponsor set forth on Schedule 1 hereto (collectively “RA Capital”), certain existing shareholders of OAKH as set forth on Schedule 2 hereto (the “OAKH Existing Investors”), certain former stockholders of OHB Pediatrics Ltd., a company incorporated under the laws of England and Wales (the “Company” or “OHB”), set forth on Schedule 3 hereto (such stockholders, the “OHB Holders”) and other persons and entities (collectively with OAKH, the Sponsor, the OHB Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to Section*** 5.2*

…